摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 7-(4-(3-ethynylbenzylamino)-7-methoxyquinazolin-6-yloxy)heptanoate | 1012057-91-8

中文名称
——
中文别名
——
英文名称
ethyl 7-(4-(3-ethynylbenzylamino)-7-methoxyquinazolin-6-yloxy)heptanoate
英文别名
Ethyl 7-[4-[(3-ethynylphenyl)methylamino]-7-methoxyquinazolin-6-yl]oxyheptanoate
ethyl 7-(4-(3-ethynylbenzylamino)-7-methoxyquinazolin-6-yloxy)heptanoate化学式
CAS
1012057-91-8
化学式
C27H31N3O4
mdl
——
分子量
461.561
InChiKey
YLSSVPOKPYJTMQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.3
  • 重原子数:
    34
  • 可旋转键数:
    15
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.37
  • 拓扑面积:
    82.6
  • 氢给体数:
    1
  • 氢受体数:
    7

文献信息

  • QUINAZOLINE BASED EGFR INHIBITORS CONTAINING A ZINC BINDING MOIETY
    申请人:Qian Changgeng
    公开号:US20080194578A1
    公开(公告)日:2008-08-14
    The present invention relates to quinazoline containing zinc-binding moiety based derivatives that have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.
    本发明涉及含有结合基团的喹唑啉生物,具有增强和意外的抑制表皮生长因子受体酪氨酸激酶(EGFR-TK)的性质,并可用于治疗EGFR-TK相关的疾病和疾病,如癌症。所述衍生物还可以作为HDAC抑制剂
  • Multi-Functional Small Molecules as Anti-Proliferative Agents
    申请人:Cai Xiong
    公开号:US20080221132A1
    公开(公告)日:2008-09-11
    The present invention relates to the compositions, methods, and applications of a novel approach to selective inhibition of several cellular or molecular targets with a single small molecule. More specifically, the present invention relates to multi-functional small molecules wherein one functionality is capable of inhibiting histone deacetylases (HDAC) and the other functionality is capable of inhibiting a different cellular or molecular pathway involved in aberrant cell proliferation, differentiation or survival.
    本发明涉及一种新型选择性抑制多种细胞或分子靶点的组合物、方法和应用。更具体地说,本发明涉及多功能小分子,其中一种功能能够抑制组蛋白去乙酰化酶(HDAC),另一种功能能够抑制与异常细胞增殖、分化或存活有关的不同细胞或分子途径。
  • MULTI-FUNCTIONAL SMALL MOLECULES AS ANTI-PROLIFERATIVE AGENTS
    申请人:Curis, Inc.
    公开号:EP2061772A2
    公开(公告)日:2009-05-27
  • US8604044B2
    申请人:——
    公开号:US8604044B2
    公开(公告)日:2013-12-10
  • US9024024B2
    申请人:——
    公开号:US9024024B2
    公开(公告)日:2015-05-05
查看更多